FDA
-
-
-
-
-
-
-
Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
-
-
-
-
-
-
-
Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
-
-
-
-
-
-
-
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
-
-
-
-
-
-
-
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
-
-
-
-
-
-
-
Citius Pharmaceuticals (CTXR) Acquires Dr. Reddy's (RDY) Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indicatio
-
-
-
-
-
-
-
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
-
323,754 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

